Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Keith Katkin currently holds 25,748 shares of Urovant Sciences Ltd. (UROV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Keith Katkin has been a net seller of UROV stock. They have purchased $55.2K and sold $13.9M worth of shares.
Keith Katkin's most recent insider trade was on May 23, 2024, when they sold 25,748 shares at $0.00 per share.
Keith Katkin serves as Executive at Urovant Sciences Ltd. (UROV). They have executed 124 insider transactions totaling $13.9M over their tenure at the company.
Keith Katkin holds the position of Executive at Urovant Sciences Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Keith Katkin has shown a selling trading pattern, with $55.2K in total purchases and $13.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Keith Katkin was on Dec 15, 2014, when they sold $3.3M worth of AVNR shares. This transaction involved 195,160 shares at $16.95 per share.
Keith Katkin currently owns 25,748 shares of Urovant Sciences Ltd. (UROV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Keith Katkin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Keith Katkin has 124 Form 4 filings on record as an insider at Urovant Sciences Ltd..
Set alerts for Keith Katkin and 40,000+ other insiders.